21. Radical (chemo)radiotherapy in oropharyngeal squamous cell carcinoma: Comparison of TNM 7th and 8th staging systems. (April 2020) Authors: De Felice, F.; Bird, T.; Michaelidou, A.; Thavaraj, S.; Odell, E.; Sandison, A.; Hall, G.; Morgan, P.; Lyons, A.; Cascarini, L.; Fry, A.; Oakley, R.; Simo, R.; Jeannon, J.P.; Lei, M.; Guerrero Urbano, T. Journal: Radiotherapy and oncology Issue: Volume 145(2020) Page Start: 146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Study of the production of and hadrons in pp collisions and first measurement of the branching fraction *Supported by CERN and national agencies: CAPES, CNPq, FAPERJ and FINEP (Brazil); NSFC (China); CNRS/IN2P3 (France); BMBF, DFG, HGF and MPG (Germany); INFN (Italy); FOM and NWO (The Netherlands); MNiSW and NCN (Poland); MEN/IFA (Romania); MinES and FANO (Russia); MinECo (Spain); SNSF and SER (Switzerland); NASU (Ukraine); STFC (United Kingdom); NSF (USA). The Tier1 computing centres are supported by IN2P3 (France), KIT and BMBF (Germany), INFN (Italy), NWO and SURF (The Netherlands), PIC (Spain), GridPP (United Kingdom). Individual groups or members have received support from EPLANET, Marie Skłodowska-Curie Actions and ERC (European Union), Conseil général de Haute-Savoie, Labex ENIGMASS and OCEVU, Région Auvergne (France), RFBR (Russia), XuntaGal and GENCAT (Spain), Royal Society and Royal Commission for the Exhibition of 1851 (United Kingdom). (January 2016) Authors: Aaij, R.; Adeva, B.; Adinolfi, M.; Affolder, A.; Ajaltouni, Z.; Akar, S.; Albrecht, J.; Alessio, F.; Alexander, M.; Ali, S.; Alkhazov, G.; Alvarez Cartelle, P.; Alves, A.A.; Amato, S.; Amerio, S.; Amhis, Y.; An, L.; Anderlini, L.; Anderson, J.; Andreassi, G. Other Names: collab. Journal: Chinese physics C Issue: Volume 40:Number 1(2016:Jan.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. The TBL1 inhibitor, Tegavivint, suppresses tumour growth and enhances T-cell infiltration in preclinical murine β-Catenin mutant hepatocellular carcinoma. (October 2022) Authors: Drake, T.; Tan, E.H.; Georgakopoulou, A.; May, S.; Mueller, M.; Horrigan, S.; Holloway, K.; Chang, J.; Aras, R.; Bird, T. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗